JMP Securities cut shares of Expensify (NASDAQ:EXFY – Free Report) from an outperform rating to a market perform rating in a research note published on Monday morning, MarketBeat.com reports.
Expensify Trading Down 2.1 %
Shares of EXFY stock opened at $3.27 on Monday. Expensify has a 12 month low of $1.24 and a 12 month high of $3.47. The stock has a market cap of $252.31 million, a P/E ratio of -18.17 and a beta of 1.51. The company has a 50 day simple moving average of $2.20 and a two-hundred day simple moving average of $1.98.
Insider Buying and Selling at Expensify
In related news, CEO David Michael Barrett sold 15,454 shares of the business’s stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $2.91, for a total value of $44,971.14. Following the sale, the chief executive officer now owns 2,378,319 shares in the company, valued at approximately $6,920,908.29. The trade was a 0.65 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Ryan Schaffer sold 12,500 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $2.27, for a total transaction of $28,375.00. Following the sale, the chief financial officer now owns 152,531 shares in the company, valued at $346,245.37. This represents a 7.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 185,607 shares of company stock valued at $485,361 over the last ninety days. 17.33% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Expensify
Expensify Company Profile
Expensify, Inc provides a cloud-based expense management software platform to individuals and corporations, small and midsized businesses, and enterprises in the United States and internationally. The company’s platform enables users to manage corporate cards, pay bills, generate invoices, collect payments, and book travel.
Featured Articles
- Five stocks we like better than Expensify
- How to Buy Cheap Stocks Step by Step
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Business Services Stocks Investing
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Quiet Period Expirations Explained
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Expensify Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Expensify and related companies with MarketBeat.com's FREE daily email newsletter.